Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations (LCA)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Samuel G. Jacobson, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00481546
First received: May 31, 2007
Last updated: May 26, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2026
  Estimated Primary Completion Date: June 2026 (Final data collection date for primary outcome measure)
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):